2011 · 11 citations · 0 references
PharmacyPharmacologyToxicologyControlled Substance PolicyPsychopharmacologySubstance Use DisordersAddictionDrug DependenceDrugs Of AbuseStimulant ToxicologyStimulant Use DisordersSubstance Abuse PreventionDrug Misuse EpidemiologyDrug Use EpidemiologyLifetime AnalysisOpioid Use EpidemiologyProblematic Drug UseStimulant DependenceStimulant SalesSubstance Use Epidemiology
This report finds that use of mephedrone, a synthetic stimulant, has increased in recent years, particularly in the UK, Europe and Australia. The report also finds that: • One-fifth (21%) of the 2010 national regular ecstasy user sample reported lifetime use of mephedrone and 17% reported use of mephedrone in the six months preceding the interview. • Mephedrone was typically swallowed or snorted on a median frequency of 3 days or approximately once every two months. • Use of mephedrone was most common in particular jurisdictions such as Tasmania (47%) and Victoria (28%) followed